Nantahala Capital Management, LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1472322
New Canaan, CT
Position in CATX
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$7,929,784
New position
Shares Held
2,325,450
first reported quarter
Ownership
2.04%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#13
of 131 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Nantahala Capital Management, LLC holds $224,907,183 across 15 Medical Devices names. CATX ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
|
6,000,279 | $56,642,633 | |
| 2 | AVR |
Anteris Technologies Global Corp.
|
3,383,335 | $33,325,849 | |
| 3 | ESTA |
Establishment Labs Holdings Inc.
|
335,830 | $28,817,572 | |
| 4 | XTNT |
Xtant Medical Holdings, Inc.
|
68,394,000 | $28,725,480 | |
| 5 | APYX |
Apyx Medical Corp
|
3,270,248 | $14,683,413 | |
| 6 | INSP |
Inspire Medical Systems, Inc.
|
269,474 | $12,021,235 | |
| 7 | ITGR |
Integer Holdings Corp
|
111,302 | $10,401,171 | |
| 8 | CATX |
Perspective Therapeutics, Inc.
This page
|
2,325,450 | $7,929,784 |
All Filings in CATX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,929,784 | 2,325,450 | Shares | Sole | 2026-08-19 | |
| No filing history on record for this holder in this stock. | ||||||